# Cilostazol Following Peripheral Endovascular Procedures

> **NCT02770274** · PHASE3 · UNKNOWN · sponsor: **Attikon Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Cilostazol
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT02770274
- **Lead sponsor:** Attikon Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02770274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02770274, "Cilostazol Following Peripheral Endovascular Procedures". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02770274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*